Quantitation of hexahydrocannabinol (HHC) and metabolites in blood from DUID cases
Journal of Analytical Toxicology · 2024
DOI: 10.1093/jat/bkae030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analytical Toxicology, 2024. Verfasst von Robert Kronstrand und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Artillerigatan 12, Linköping 587 58, Sweden. Hauptthemen laut MEDLINE: Dronabinol, Substance Abuse Detection, Tandem Mass Spectrometry. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Hexahydrocannabinol (HHC) was first reported in the EU in May 2022. HHC has three chiral carbon atoms, but only (6aR,9R,10aR)-HHC (9R-HHC) and (6aR,9S,10aR)-HHC (9S-HHC) have been encountered in HHC products. The aim of this study was to develop and validate a method for the quantitative analysis of 9R-HHC, 9S-HHC, 11-OH-9R-HHC, 9R-HHC-COOH, 9S-HHC-COOH and 8-OH-9R-HHC. In addition, an objective was to investigate the immunochemical cross-reactivity. Blood samples from driving under the influence of drugs (DUID) cases screened positive for cannabis using enzyme-linked immunoadsorbent assay (ELISA) and confirmed negative for tetrahydrocannabinol (THC), 11-hydroxy-THC and THC-COOH were reanalyzed with a newly validated HHC method to investigate the presence of HHC and metabolites. The LC–MS-MS method was validated for matrix effects, lower limit of quantification (LLOQ), calibration model, precision, bias and autosampler stability. Cross-reactivity on an ELISA method was investigated separately for 9R-HHC-COOH and 9S-HHC-COOH at a concentration range between 5 and 200 ng/mL. The cross-reactivity was found to be 120% for 9R-HHC-COOH and 48% for 9S-HHC-COOH. In the LC–MS-MS method, 9R-HHC-COOH, 9S-HHC-COOH and 11-OH-9R-HHC showed matrix effects <25% at both concentrations, while 8-OH-9R-HHC, 9R-HHC and 9S-HHC matrix effects exceeded 25% at both concentrations but showed good precision (<10% for both inter and intra day) and low bias (<6%) in the further validation. The LLOQ was investigated and established at 0.2 ng/mL for all analytes except the carboxylated metabolites that had an LLOQ of 2.0 ng/mL. The upper LOQ was 20 and 200 ng/mL, respectively. Reanalysis of cases (n = 145) confirmed HHC and metabolites in 32 cases (22%). It was determined that the major metabolite in blood after administration of HHC was 9R-HHC-COOH followed by 11-OH-9R-HHC and that presumptive positive cases are caught by the routine ELISA screening for cannabis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Artillerigatan 12, Linköping 587 58, Sweden.
- Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping 581 83, Sweden.
- Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, 4800 SW 35th Drive, Gainesville, FL 32610, USA.
ORCID-Profile: Robert Kronstrand, Michael T Truver
Zitieren
APA
Kronstrand, R., Roman, M., Green, H., & Truver, M. T. (2024). Quantitation of hexahydrocannabinol (HHC) and metabolites in blood from DUID cases. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkae030
Vancouver
Kronstrand R, Roman M, Green H, Truver MT. Quantitation of hexahydrocannabinol (HHC) and metabolites in blood from DUID cases. Journal of Analytical Toxicology. 2024. doi:10.1093/jat/bkae030
BibTeX
@article{Kronstrand2024,
author = {Kronstrand, Robert and Roman, Markus and Green, Henrik and Truver, Michael T},
title = {Quantitation of hexahydrocannabinol (HHC) and metabolites in blood from DUID cases},
journal = {Journal of Analytical Toxicology},
year = {2024},
doi = {10.1093/jat/bkae030}
}
EUVIMED